Citation: B. Drukarch et Fl. Van Muiswinkel, Neuroprotection for Parkinson's disease: a new approach for a new millennium, EXPERT OP I, 10(10), 2001, pp. 1855-1868
Authors:
van Muiswinkel, FL
Riemers, FM
Peters, GJ
LaFleur, MVM
Siegel, D
Jongenelen, CAM
Drukarch, B
Citation: Fl. Van Muiswinkel et al., L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H : quinone oxidoreductase (NQO) in cultured astroglial cells, FREE RAD B, 29(5), 2000, pp. 442-453
Authors:
Stoof, JC
Winogrodzka, A
van Muiswinkel, FL
Wolters, EC
Voorn, P
Groenewegen, HJ
Booij, J
Drukarch, B
Citation: Jc. Stoof et al., Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy, EUR J PHARM, 375(1-3), 1999, pp. 75-86
Authors:
van Muiswinkel, FL
De Groot, CJA
Rozemuller-Kwakkel, JM
Eikelenboom, P
Citation: Fl. Van Muiswinkel et al., Enhanced expression of microglial NADPH-oxidase (p22-phox) in Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 451-455
Authors:
Smits, HA
van Muiswinkel, FL
de Vos, NM
Verhoef, J
Nottet, HSLM
Citation: Ha. Smits et al., The amyloid-beta 1-42-induced respiratory burst of primary human macrophages is enhanced in the presence of amyloid-beta 25-35, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 457-461
Authors:
Eikelenboom, P
Rozemuller, JM
van Muiswinkel, FL
Citation: P. Eikelenboom et al., Inflammation and Alzheimer's disease: Relationships between pathogenic mechanisms and clinical expression, EXP NEUROL, 154(1), 1998, pp. 89-98